
Sarepta Therapeutics
The Leader in RNA-based Medicine | Sarepta Therapeutics.
Market cap
$1.7b
Enterprise value
$2.5b
Share price
$17.10 SRPT
Recent deals
- Healthcare
Authorizing premium user...
The Leader in RNA-based Medicine | Sarepta Therapeutics.